Insider Transactions in Q1 2025 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2025
|
Joanne Quan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,969
-55.23%
|
$313,605
$45.86 P/Share
|
|
Jan 16
2025
|
Joanne Quan CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+49.77%
|
-
|
|
Jan 07
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,489
-5.9%
|
$314,538
$42.82 P/Share
|
|
Jan 07
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,998
-6.89%
|
$83,916
$42.82 P/Share
|
|
Jan 07
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
750
-20.4%
|
$31,500
$42.82 P/Share
|
|
Jan 06
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+25.38%
|
-
|